Another trial published in The Lancet in 2017 demonstrated that exenatide (Byetta) improved motor function in patients with Parkinson's disease, with some exploratory cognitive measures showing potential benefit, though the study was limited by small sample size and short duration
Retatrutide (LY-3437943): Eli Lilly Retatrutide is a biologic entity that acts as a triagonist for the gastric inhibitory polypeptide (GIP) receptor, the GLP-1 receptor and the glucagon receptor
Key Takeaways On a GLP-1, protein needs to come first at each meal, both in order of eating and in priority, because total food intake is so reduced
They can help you find safe and sustainable options
Genetic testing does not predict how you will respond to a weight loss medication
We all need protein, one of the Big Three in our diet: proteins, fats, carbohydrates